Equity
€418,727 ▲ 93.8%
BIOTECH ENGINEERING has made a profit in every financial year since 2007.
BIOTECH ENGINEERING
Lifetime
19 annual accounts with figures on one time axis, 28 filings since 1998peak €419,085 (2025)
€419,085▲ 267%
peak €242,696 (2025)
€242,696▲ 229×
peak €564,688 (2022)
€418,727▲ 93.8%
€368,887▲ 10.0%
peak 3 FTE (2008)
-not published
Board5 names since 2018
2 directors and 1 other
Owners
75%
Documentsfilings and deeds
04-08-202588 days before the deadline
2025micro format
Gross margin from €114,149 to €419,085Result from €1,058 to €242,696Equity from €216,032 to €418,727Cash from €366,494 to €516,297
Key points
from the 2025 annual accountsResult
€242,696 ▲ 229×
The result rose in 2025 from €1,058 to €242,696.
Filings
28 annual accounts 29 filings, 12 days past the deadline
2026 accounts not filed: deadline was 31-10-2026.
At the same address
72 companies
Board
1 joined · 2 left
Board changed. Latest change 05-03-2026 · 2 in office.
Position in the sector
€242,696
Higher net result than 95% of companies in architecture and engineering. Sector median €16,690 · 11,795 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,356 companies had the same profile as BIOTECH ENGINEERING has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,356 companies, not a prediction for BIOTECH ENGINEERING. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, , since 01-10-2018
Director,
- 75%score equity €1.7m (2025) · 30-09-2025 annual accounts of
Recent changes
Permanent representative:
General meeting of 05-03-2026 · Gazette deed
Registered office moved from Tournai to Ghent
New registered office: Amelia Earhartlaan 2, boîte 304, 9051 Gent (Sint-Denijs-Westrem) · Previous registered office: Rue de la Grande Couture 2, 7522 Tournai · Resignations: ; and · General meeting of 05-03-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0460320725
1 director appointed
Change of role: , from manager to director · Appointment: (director) · Permanent representative: · General meeting of 01-12-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BIOTECH ENGINEERING Ghent | €787,615 | €419,085 | 53.2% | - |
| GELDOF MILIEU CONSULT Sint-Niklaas | €790,367 | €439,368 | 73.8% | - |
| JLB ENGINEERING Hulshout | €816,556 | €427,964 | 59.9% | - |
| ENMO SERVICES Vosselaar | €698,042 | €395,439 | 7.2% | 4 |
| Valmet Belgium Aartselaar | €723,650 | €472,543 | -120.1% | - |
| ACOUSTICAL ENGINEERING Sint-Katelijne-Waver | €663,788 | €415,761 | 61.7% | - |
| IN.ZO Leopoldsburg | €726,385 | €487,031 | 18.6% | 5.9 |
These companies have the same main activity as BIOTECH ENGINEERING: engineering and related technical consultancy, excluding land surveyors (NACE 71121). They are comparable in size and age: total assets between €664,000 and €817,000, founded between 1994 and 2000.
Official details
Source: KBO- Status
- Active since 28-03-1997Normal situation
- Registered office
- 73 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 11 November 2026.
- Activity
- Engineering and related technical consultancy, excluding land surveyorsNACE 71121
- Establishment unit
- 2.081.134.2087522 Tournai, since 01-04-1997
- Financial year end
- 31 March
- Peppol
- Reachable since 19-12-2025
Annual accounts to 31-03-2025
- ≈ €1.0mestimated
- €787,615▲ 42.8%
- Employeeson 31-03-2025
- 1=
- Filing
- Filed on 04-08-2025
Insights on BIOTECH ENGINEERING
BIOTECH ENGINEERING files the micro format. That format states no turnover. The gross margin rose from €189,733 in 2007 to €419,085 in 2025.
holds 75% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BIOTECH ENGINEERING
- What is the company number of BIOTECH ENGINEERING?
- The company number of BIOTECH ENGINEERING is 0460.320.725. The VAT number is the same number with BE in front: BE 0460.320.725.
- Where is BIOTECH ENGINEERING based?
- The registered office is at Amelia Earhartlaan 2, 9051 Ghent.Company details
- What does BIOTECH ENGINEERING do?
- According to the KBO register, the main activity is engineering and related technical consultancy, excluding land surveyors (NACE 71121).
- What is the legal form of BIOTECH ENGINEERING?
- BIOTECH ENGINEERING is a private limited company (BV).
- When was BIOTECH ENGINEERING founded?
- BIOTECH ENGINEERING was founded on 28-03-1997.
- Is BIOTECH ENGINEERING still active?
- Yes, BIOTECH ENGINEERING is an active enterprise in the KBO register.
- How many employees does BIOTECH ENGINEERING have?
- BIOTECH ENGINEERING had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BIOTECH ENGINEERING?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €419,085 and 40 comparable companies (NACE 711). It probably lies between €730,000 and €1.4m.
- Is BIOTECH ENGINEERING profitable?
- In financial year 2025, BIOTECH ENGINEERING made a profit of €242,696.
- Where can I find the annual accounts of BIOTECH ENGINEERING?
- BIOTECH ENGINEERING filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.